News & Updates

Show Multimedia Only
Boosting potassium wards off ventricular arrhythmias in patients with ICD
Boosting potassium wards off ventricular arrhythmias in patients with ICD
07 Oct 2025 byElvira Manzano

Increasing low potassium levels improves clinical outcomes in patients with cardiovascular disease (CVD) and a high risk for ventricular arrhythmias, as shown in the POTCAST trial presented at ESC 2025.

Boosting potassium wards off ventricular arrhythmias in patients with ICD
07 Oct 2025
Old cardio drug pulls a surprise in DIGIT-HF trial
Old cardio drug pulls a surprise in DIGIT-HF trial
04 Oct 2025 byElvira Manzano

Adding the cardiac glycoside digitoxin to guideline-directed medical therapy (GDMT) improves clinical outcomes in patients with heart failure with reduced ejection fraction (HFrEF), as shown in the DIGIT-HF trial, which took over 10 years to complete due to funding constraints.

Old cardio drug pulls a surprise in DIGIT-HF trial
04 Oct 2025
Obesity, smoking tied to 5-FU-induced cardiotoxicity in cancer patients
Obesity, smoking tied to 5-FU-induced cardiotoxicity in cancer patients
29 Sep 2025 byStephen Padilla

Smoking, obesity, treatment duration, and pre-existing cardiac diseases may contribute to the development of cardiotoxicity among patients with cancer who are undergoing 5-fluorouracil (5-FU) chemotherapy, suggests a recent study.

Obesity, smoking tied to 5-FU-induced cardiotoxicity in cancer patients
29 Sep 2025